By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ono Pharmaceutical Company, Ltd. 

2-1-5 Doshomachi
Osaka    541-8526  Japan
Phone: 06-6222-5551 Fax:



Company News
Array BioPharma (ARRY) And Ono Pharma (OPHLY) Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib 5/31/2017 7:05:22 AM
Numab AG And Ono Pharma (OPHLY) Enter Into A Research And Option Agreement 3/28/2017 7:13:42 AM
X-Chem And Ono Pharma (OPHLY) Enter Into Multi-Target Drug Discovery Collaboration 3/21/2017 9:56:45 AM
Ligand (LGND) Enters Into Worldwide OmniAb Platform License Agreement With Ono Pharma (OPHLY) 12/22/2016 11:03:26 AM
Merus (MRUS) Receives Milestone Payment From Ono Pharma (OPHLY) For Selection Of Bispecific Antibody Candidate For Clinical Development And Extends Partnership With CMC Service Agreement 10/19/2016 7:49:51 AM
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging 8/8/2016 6:34:42 AM
Celyad Hammers Out NKR-2 T-cell Immunotherapy Deal Worth $311.5 Million with Ono Pharma 7/11/2016 6:06:18 AM
How a $150,000 Drug Created with Bristol-Myers Squibb (BMY) Saved Ono Pharma 3/4/2016 7:06:29 AM
Ono Pharmaceutical Company, Ltd. Transforms Its High-Throughput Screening With Genedata AG Screener 2/23/2016 10:03:05 AM
Ono Pharmaceutical Company, Ltd. Selects Medidata To Power Clinical Trials Exploring Additional Cancer Indications For Immunotherapy Drug OPDIVO (Nivolumab) 1/27/2016 10:16:06 AM